
Omadacycline and Clostridioides difficile: A Systematic Review of Preclinical and Clinical Evidence
Author(s) -
Kevin W. Garey,
Warren E. Rose,
Kyle Gunter,
Alisa W. Serio,
Mark H. Wilcox
Publication year - 2022
Publication title -
annals of pharmacotherapy/the annals of pharmacotherapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.926
H-Index - 113
eISSN - 1542-6270
pISSN - 1060-0280
DOI - 10.1177/10600280221089007
Subject(s) - medicine , clostridioides , clostridium difficile , adverse effect , antibiotics , microbiology and biotechnology , biology
The objective of this systematic review is to summarize in vitro, preclinical, and human data related to omadacycline and Clostridioides difficile infection (CDI).